Stock listing

BCAX Stock Price, News, Filings & Events — Bicara Therapeutics Inc.

Selected listing: BCAX · BOATS · USD · US

This page tracks Bicara Therapeutics Inc.'s BCAX:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following BCAX:BOATS. BCAX:BOATS is the stock-level entry point for investors researching Bicara Therapeutics Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Bicara Therapeutics Inc. is a public company traded under the ticker BCAX in the American market. The company has a market capitalization of approximately $1.82 billion. Bicara focuses on developing innovative therapies, leveraging its expertise to advance treatment options in the healthcare sector.

BCAX:BOATSUSDUSUpdated August 28, 2026
Bicara Therapeutics Inc. logo
Ticker
BCAX:BOATS
Asset type
Stock
Market cap
$1.55B
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
BOATS
Currency
USD

Bicara Therapeutics Inc. BCAX:BOATS stock context

This page tracks Bicara Therapeutics Inc.'s BCAX:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following BCAX:BOATS. BCAX:BOATS is the stock-level entry point for investors researching Bicara Therapeutics Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Bicara Therapeutics Inc. is a public company traded under the ticker BCAX in the American market. The company has a market capitalization of approximately $1.82 billion. Bicara focuses on developing innovative therapies, leveraging its expertise to advance treatment options in the healthcare sector.

Latest news from Bicara Therapeutics Inc.

All Bicara Therapeutics Inc. news →

Bicara Therapeutics Inc. earnings calls

Research Bicara Therapeutics Inc.

Alternate listings